Results
Results of past studies
Treatments that research like ours helped bring to patients.
Chemo, Laboratorios León Farma: Birth Control
Exeltis announced FDA approval of Slynd (drospirenone) for prescription use in the United States.
Press release (PDF) →AbbVie: Endometriosis
AbbVie received U.S. FDA approval of ORILISSA (elagolix) for the management of moderate to severe pain associated with endometriosis.
Press release (PDF) →Endoceutics: Vaginal Atrophy
Endoceutics received Health Canada approval for Intrarosa, the first innovative drug for the treatment of vulvovaginal atrophy with prasterone.
Press release (PDF) →Regeneron
Regeneron and Sanofi announced that dupilumab received FDA Breakthrough Therapy Designation in atopic dermatitis.
Press release (PDF) →